. Author manuscript; available in PMC: 2022 Jun 1.

Published in final edited form as: Am J Psychiatry. 2021 Jan 21;178(6):548–559. doi: 10.1176/appi.ajp.2020.20050610

Table 3:

Trends in WHO risk drinking levels, 2001–2002 (NESARC) to 2012–2013 (NESARC-III), by gender

	Men (N=24,821)						Women (N=27,493)						Trend differences, men vs. women^d
	2001–2002^a		2012–2013^a		Prevalence difference^c		2001–2002^a		2012–2013^a		Prevalence difference^c
WHO risk level	Prevalence^b		Prevalence^b		Prevalence difference^c		Prevalence^b		Prevalence^b		Prevalence difference^c
%	SE	%	SE	%	95%CI	%	SE	%	SE	%	95%CI	%	95%CI
	%	SE	%	SE	%	95% CI	%	SE	%	SE	%	95% CI	%	95% CI
Very high	3.3	.19	3.7	.24	+0.5	−0.09, 1.09	1.8	.18	3.3	.17	+1.4	0.93, 1.87	−1.0	−1.69, −0.31
High	3.4	.21	4.0	.24	+0.6	−0.03, 1.23	1.7	.15	2.2	.17	+0.5	0.05, 0.95	+0.1	−0.59, 0.79
Moderate	4.1	.21	5.0	.25	+0.9	0.27, 1.53	5.8	.25	6.8	.29	+1.1	0.36, 1.84	−0.2	−1.16, 0.76
Low	89.2	.38	87.2	.38	−2.0	−3.02, −0.98	90.7	.35	87.7	.42	−3.0	−4.08, −1.92	+1.0	−0.27, 2.27

CI = confidence interval

2001–2002 data from NESARC survey (n: men = 12,886; women = 13,769); 2012–2013 data from NESARC-III survey (n: men = 11,935; women = 13,724)

adjusted for sample weights and sociodemographic covariates (gender, age, education, race/ethnicity, health insurance, and current smoking)

Prevalence at 2012–2013 minus prevalence at 2001–2002 indicates the trend. Prevalence differences whose 95% CI do not include 0 are statistically significant at p<.05 and are bolded.

For each WHO risk drinking level, the trend (prevalence difference) in men minus the prevalence difference in women indicated whether change over time differs by gender. Trend differences whose 95% CI do not include 0 are statistically significant at p<.05 and are bolded.

Note that the prevalence, prevalence differences, and trends differences are rounded, such that subtracting the values may not yield the exact difference reported.